The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Relationship of adverse events after combined immunotherapy and treatment outcomes in patients with advanced melanoma: A multicenter experience in Poland.
 
Renata Pacholczak-Madej
Honoraria - Bristol Myers Squibb
Speakers' Bureau - Bristol-Myers Squibb
Travel, Accommodations, Expenses - Bristol Myers Squibb Foundation
 
Aleksandra Grela-Wojewoda
Speakers' Bureau - Amgen; Bristol-Myers Squibb; MSD; Novartis; Pfizer; Roche
Travel, Accommodations, Expenses - Novartis; Roche
 
Miroslawa Puskulluoglu
Consulting or Advisory Role - Gilead Sciences
Speakers' Bureau - AstraZeneca; Janssen; Roche
Travel, Accommodations, Expenses - Gilead Sciences; Pfizer
 
Joanna Lompart
Speakers' Bureau - Amgen; Bayer; Bristol-Myers Squibb; Ipsen; Merck; Roche
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Manuela Las-Jankowska
No Relationships to Disclose
 
Katarzyna Krawczak
No Relationships to Disclose
 
Monika Olejniczak
No Relationships to Disclose
 
Ewa Wrona
Travel, Accommodations, Expenses - Merck
 
Monika Źrebiec-Figura
Speakers' Bureau - Astellas Amgen BioPharama; AstraZeneca; Bayer; Bristol-Myers Squibb; Gilead Sciences; Ipsen; Janssen; Lekam; Merck; Novartis; Pierre Fabre
Travel, Accommodations, Expenses - MSD; Novartis
 
Justyna Żubrowska
No Relationships to Disclose
 
Tomasz Zemelka
No Relationships to Disclose
 
Marek Ziobro
Consulting or Advisory Role - Bristol Myers Squibb; Ipsen; MSD; Novartis; Pierre Fabre
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Novartis; Pierre Fabre; Roche